Amphastar Pharmaceuticals (FRA:29A) Total Assets : €1,506.5 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Amphastar Pharmaceuticals Total Assets?

Amphastar Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2024 was €1,506.5 Mil.

Warning Sign:

If a company builds assets at 24.4% a year, faster than its revenue growth rate of 17.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Amphastar Pharmaceuticals's average Total Assets Growth Rate was 7.90% per year. During the past 3 years, the average Total Assets Growth Rate was 36.40% per year. During the past 5 years, the average Total Assets Growth Rate was 24.40% per year. During the past 10 years, the average Total Assets Growth Rate was 14.50% per year.

During the past 13 years, Amphastar Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 36.40%. The lowest was 4.10%. And the median was 8.70%.

Total Assets is connected with ROA %. Amphastar Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2024 was 10.01%. Total Assets is also linked to Revenue through Asset Turnover. Amphastar Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2024 was 0.12.

Amphastar Pharmaceuticals Total Assets Historical Data

The historical data trend for Amphastar Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals Total Assets Chart

Amphastar Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

518.88

594.30

700.44

1,387.34

1,506.48

Amphastar Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															1,387.34	1,448.37	1,385.62	1,392.21	1,506.48

Amphastar Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Amphastar Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	699.345	+	807.139
	=	1,506.5

Amphastar Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	699.345	+	807.139
	=	1,506.5

Amphastar Pharmaceuticals (FRA:29A) Total Assets Explanation

Total Assets is connected with ROA %.

Amphastar Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	145.024	/	( (1392.205	+	1506.484)	/ 2 )
	=	145.024	/	1449.3445
	=	10.01 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Amphastar Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	178.129	/	( (1392.205	+	1506.484)	/ 2 )
=	178.129	/	1449.3445
=	0.12

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Amphastar Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Amphastar Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (FRA:29A) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

AMPH:USA 29A:Germany

Address

11570 6th Street, Rancho Cucamonga, CA, USA, 91730

Website

https://www.amphastar.com

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Amphastar Pharmaceuticals Headlines

No Headlines